Have a feature idea you'd love to see implemented?
Let us know!
MBIO Mustang Bio Inc
Price (delayed)
$0.3056
Market cap
$11.38M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.75
Enterprise value
$7.82M
Mustang Bio, Inc. ("Mustang") is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare
Highlights
MBIO's EPS has surged by 69% year-on-year and by 38% since the previous quarter
The company's debt has shrunk by 59% YoY and by 55% QoQ
MBIO's equity has dropped by 161% year-on-year and by 69% since the previous quarter
The quick ratio has shrunk by 73% YoY and by 29% QoQ
Key stats
What are the main financial stats of MBIO
Market
Valuations
Earnings
Shares outstanding
37.23M
Market cap
$11.38M
Enterprise value
$7.82M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$32.06M
EBITDA
-$30.63M
Free cash flow
-$20.96M
Per share
Balance sheet
Liquidity
EPS
-$2.75
Free cash flow per share
-$0.91
Book value per share
-$0.67
Revenue per share
$0
TBVPS
$0.37
Total assets
$8.52M
Total liabilities
$16.85M
Debt
$1.09M
Equity
-$8.33M
Working capital
-$8.6M
Debt to equity
-0.13
Current ratio
0.46
Quick ratio
0.34
Net debt/EBITDA
0.12
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-208.8%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MBIO stock price
How has the Mustang Bio stock price performed over time
Intraday
8.33%
1 week
39.04%
1 month
43.27%
1 year
-81.81%
YTD
-77.36%
QTD
29.88%
Financial performance
How have Mustang Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$32.82M
Net income
-$32.06M
Gross margin
N/A
Net margin
N/A
MBIO's net income has surged by 55% year-on-year and by 20% since the previous quarter
MBIO's operating income has soared by 52% YoY and by 14% from the previous quarter
Growth
What is Mustang Bio's growth rate over time
Valuation
What is Mustang Bio stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
MBIO's EPS has surged by 69% year-on-year and by 38% since the previous quarter
MBIO's equity has dropped by 161% year-on-year and by 69% since the previous quarter
Efficiency
How efficient is Mustang Bio business performance
MBIO's ROA has plunged by 122% YoY and by 7% from the previous quarter
Dividends
What is MBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MBIO.
Financial health
How did Mustang Bio financials performed over time
Mustang Bio's total assets is 49% less than its total liabilities
Mustang Bio's current ratio has shrunk by 74% YoY and by 13% QoQ
The quick ratio has shrunk by 73% YoY and by 29% QoQ
The company's debt is 113% higher than its equity
The debt to equity has shrunk by 168% YoY but it has soared by 73% QoQ
MBIO's equity has dropped by 161% year-on-year and by 69% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.